Universitair Ziekenhuis Gent

Oncology and Molecular Imaging

Universitair Ziekenhuis Gent supports research in oncology with a strong focus on imaging-based assessment and treatment selection across several malignancies, including metastatic non-small-cell lung cancer, hepatocellular carcinoma, thyroid carcinoma, head and neck squamous cell carcinoma, glioblastoma, breast cancer, and oligorecurrent prostate cancer.

  • Positron emission tomography and tumor staging
  • Prostate-specific membrane antigen-directed imaging
  • Radiotherapy and systemic treatment strategies
  • Immunotherapy in advanced solid tumors

Its research activity also includes imaging-guided evaluation of metastatic and recurrent disease, with interest in peritoneal metastases and response assessment in advanced cancer settings.

Inflammatory and Autoimmune Diseases

The sponsor is active in rheumatology and dermatology, with trials in axial spondyloarthritis, peripheral spondyloarthritis, and moderate-to-severe psoriasis, as well as symptom-focused care in rhinitis medicamentosa.

  • Spondyloarthritis disease activity assessment
  • Biologic treatment strategies
  • Immunomodulating agents
  • Inflammatory skin disease

Research in this area also covers imaging approaches to support treatment decisions and disease monitoring in chronic immune-mediated disorders.

Cardiovascular and Infectious Diseases

Cardiology studies include coronary artery disease after percutaneous coronary intervention, while infectious disease research spans bacterial infections, mycoses, systemic infections, and HIV.

  • Secondary prevention in coronary disease
  • Antimicrobial therapy in critical illness
  • HIV treatment switching
  • Bloodstream and intra-abdominal infection management

The portfolio also includes work on optimizing antimicrobial exposure in critically ill patients and evaluating treatment strategies in viral and bacterial disease.

Reproductive, Perinatal, and Neonatal Care

The sponsor’s clinical research extends to subfertility, assisted reproductive technology, fertility preservation, and neonatal care, including management of hemodynamically stable term and preterm neonates requiring intubation.

  • Ovarian stimulation strategies
  • Fertility preservation and embryo development
  • Neonatal intubation support
  • Premature and term newborn analgesia and sedation

These studies reflect interest in reproductive medicine, perinatal pharmacology, and procedural care in newborns.

Transplantation, Cellular Therapy, and Neuropsychiatry

Additional research areas include allogeneic hematopoietic stem cell transplantation, CAR-T cell therapy, and treatment-resistant depression, alongside hospital-based evaluation of psilocybin-assisted psychotherapy.

  • Fludarabine-based lymphodepletion
  • Cellular therapy support in hematologic malignancy
  • Psychiatric intervention for resistant depression
  • Transplant conditioning and pharmacokinetics

The sponsor also maintains interest in treatment-related drug exposure and supportive care in complex hematology and mental health settings.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Psilocybin Therapy for Hospitalized Patients with Treatment-Resistant Depression

    Recruiting

    2 1 1
    Belgium
  • Study on High-Dose Short-Course Antibiotics for Critically Ill Patients with Pneumonia, Intra-Abdominal, or Bloodstream Infections: Ceftriaxone, Linezolid, and Cefotaxime

    Recruiting

    3 1 1 1
    Belgium The Netherlands
  • Study on Proactive Drug Monitoring with Secukinumab, Ixekizumab, or Guselkumab for Patients with Moderate-to-Severe Psoriasis

    Recruiting

    3 1 1 1
    Investigated diseases:
    Belgium
  • Study of Amoxicillin-clavulanic acid, Piperacillin-tazobactam and Meropenem dosing in critically ill children with systemic infections

    Recruiting

    3 1 1 1
    Investigated diseases:
    Belgium
  • Study on Fludarabine, Melphalan, and ATG for Patients with Blood Cancer Undergoing Reduced Intensity Stem Cell Transplantation

    Recruiting

    3 1 1 1
    Investigated diseases:
    Belgium
  • Study Comparing Corifollitropin Alfa and Modified Natural Cycles for Women with Subfertility and Low Ovarian Response

    Recruiting

    3 1 1 1
    Belgium